ANIK vs SPGI · rev $62.2M vs P/E 27, rev $15.34B
Anika Therapeutics Inc (ANIK) versus S&P Global Inc (SPGI) — a side-by-side from cached financials, not a winner call.
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Latest reported ANIK revenue for 2026-06-30 was $62.2M. Net income was -$1.7M. ANIK currently screens at market cap $161.3M.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
ANIK currently screens at market cap $161.3M. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Not investment advice. Open the ANIK and SPGI stock pages for the full models.
Not investment advice.